1. Corporate Officers - H
2. Hirsch Andrew

Insider Trading History of Hirsch Andrew

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Hirsch Andrew since 2019. This trader's CIK number is 1586707. At the time of last reporting, Hirsch Andrew was the President & CEO of C4 Therapeutics, Inc.. (stock ticker symbol CCCC). Also see all insider trading activities at C4 Therapeutics, Inc..

Note that in the past Hirsch Andrew also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Agios Pharmaceuticals, Inc. (AGIO) by Hirsch Andrew

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2020	AGIO	0	$0	0	$0	17,363	$0
2019	AGIO	0	$0	0	$0	17,750	$0

Yearly summary of insider trading at C4 Therapeutics, Inc. (CCCC) by Hirsch Andrew

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2024	CCCC	0	$0	0	$0	20,000	$0
2023	CCCC	0	$0	0	$0	20,000	$0
2022	CCCC	10,000	$84,000	0	$0	12,500	$0

Insider trading activities at 2 companies by Hirsch Andrew:

1. Agios Pharmaceuticals, Inc. (AGIO)

2. C4 Therapeutics, Inc. (CCCC)

Table 1. Insider trading of Agios Pharmaceuticals, Inc. (AGIO) by Hirsch Andrew

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2020-04-22	AGIO	Option Ex	5,893	.00	0
2020-04-13	AGIO	Option Ex	5,387	.00	0
2020-02-22	AGIO	Option Ex	3,333	.00	0
2020-02-16	AGIO	Option Ex	2,750	.00	0
2019-02-16	AGIO	Option Ex	2,750	.00	0
2019-01-20	AGIO	Option Ex	15,000	.00	0

Table 2. Insider trading of C4 Therapeutics, Inc. (CCCC) by Hirsch Andrew

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2024-11-07	CCCC	Option Ex	12,500	.00	0
2024-09-16	CCCC	Option Ex	7,500	.00	0
2023-08-30	CCCC	Option Ex	7,500	.00	0
2023-01-30	CCCC	Option Ex	12,500	.00	0
2022-05-25	CCCC	Option Ex	12,500	.00	0
2022-04-12	CCCC	Buy	10,000	8.40	84,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hirsch Andrew (President & CEO of C4 Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month